Pediatric RSV Vaccine Safety Casts A ‘Long Shadow’ For US FDA

 
• By Michael McCaughan
  
The VRBPAC's message that safeguards were effective in pediatric vaccine trials may not be the last word on the subject. (Shutterstock)

More from Vaccines

More from Pathways & Standards